RGLS Chart
- 52-Week Range: $0.79 - $1.85
- Market Capitalization: $24.94M
- Short Percentage: 0%
- Target Price: $5.50
- Shares Outstanding: 19.48M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
RGLS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Regulus Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth ConferencePRNewsWire | August 2nd
- Regulus Therapeutics to Present at the H.C. Wainwright 2nd Annual Kidney ConferencePRNewsWire | July 18th
- Regulus Therapeutics, Inc. (RGLS) CEO Joseph Hagan on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha | August 11th
Company Info
Website: https://www.regulusrx.com
Address: 4224 Campus Point Court, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 30
Address: 4224 Campus Point Court, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 30
$RGLS Waiting waiting waiting — you know for what !!! Announcement!!!
$RGLS Another boring day I believe
$RGLS Chill out and chill some more. It's all temporary.
$RGLS said y’all dumb af
$RGLS Hedgies
we aren't going anywhere!
$RGLS Buy now
$RGLS almost time for the running
$RGLS fake wall lets break it
$RGLS Just buy and hold
$RGLS I’m selling y’all have fun bag holding